Senior Associate Director, Oncology Field Based Medicine
Oncology Competitive Intelligence Leaders

After building landscapes, covering medical conferences, and doing years of surveillance, each cancer area analyst develops cutting-edge expertise in their area and has immediate access to a comprehensive suite of CI resources.
This powerful combination enables ONCrg to provide best-in-class CI support and respond to Biopharma, CRO and Cancer Research Centers’ important questions with speed, depth and accuracy.
Solid Tumors |
||||
| GI - Gastrointestinal | GU - Genitourinary | Breast / Gyn | Lung | Other |
| Colorectal | Bladder | Breast | NSCLC | Gliomas |
| Esophageal | Prostate | Endometrial | SCLC | HNSCC |
| Gastric | RCC | Ovarian | Melanoma | |
| HCC | STS | |||
| Pancreatic | ||||
Immuno-Oncology |
MOAs |
Hematologic Malignancies |
||
| Emerging IO | ADC | ALL | MDS | MPNs |
| Late Stage IO | Cell Therapies | AML | MM | NHL |
| Emerging Clinical Signals | CLL | |||
| DDR | ||||
